$100/hour for advising pharma company - Advanced Prostate...

Advanced Prostate Cancer

21,211 members26,471 posts

$100/hour for advising pharma company

Darryl profile image
DarrylPartner
6 Replies

Myovant Sciences, Inc. is currently seeking patients living with

advanced and metastatic hormone-sensitive prostate cancer, and/or

their caregivers who may be interested in sharing their experiences

with the company.

Desired Patient/Caregiver Criteria:

* Living with or caring for someone living with advanced and

metastatic hormone-sensitive prostate cancer

* Adult 18 years of age or older

* Good relationship with their healthcare team

Call: 1-844-674-3520

or

Email: elizabeth@mypatientstory.com

Candidates will go through a screening process; therefore, there is a

chance not everyone screened will be able to participate. Participants

will be compensated for their time at $100/hour

Written by
Darryl profile image
Darryl
Partner
To view profiles and participate in discussions please or .
Read more about...
6 Replies
jmurgia profile image
jmurgia

I'll get on it later today. I'm almost having a second career with these interviews.

V10fanatic profile image
V10fanatic

Thanks for the information.

51na1a profile image
51na1a

May I call Friday to see if I may be eligible to participate

I would appreciate the opportunity to assist others and would have appretciated help In my current 5 -6 he (losing) battle.

Darryl profile image
DarrylPartner in reply to 51na1a

Yes. Call Friday

51na1a profile image
51na1a

I did and glad I did.

I do desire to participate to my fullest.

JRPnSD profile image
JRPnSD

Initial contact when I called wanted too much personally identifiable information while being unable to give me any information on the nature of what they are doing. I will await a call back and some additional info, before sharing my info. I will share what I learn and comfort level with process.

You may also like...

UK - Abiraterone too expensive for non-CRPC mPCa?

treatment for patients with newly diagnosed, high-risk hormone-sensitive metastatic prostate...

Just hit the news stand

intermittent vs continuous ADT in metastatic hormone-sensitive prostate cancer, a nadir PSA level <...

FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer

olutamide-plus-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer More info:...

Chemotherapy produces significant cognitive impairment in breast cancer patients

funding than prostate cancer. There are many similarities between breast and prostate cancers....

Good News Story from Australia: Apalutamide to become available on PBS for men living with mHSPC

across the country.  Men living with metastatic hormone sensitive prostate cancer will be able...